-+ 0.00%
-+ 0.00%
-+ 0.00%

Morgan Stanley Maintains Underweight on Adient, Lowers Price Target to $17

Benzinga·03/03/2025 17:39:33
Listen to the news
Morgan Stanley analyst Adam Jonas maintains Adient (NYSE:ADNT) with a Underweight and lowers the price target from $19 to $17.